Mike Poole

Mike Poole is a highly accomplished professional with a diverse educational background and extensive experience in the fields of neurology, internal medicine, and biotechnology.

He pursued his MD degree at the University of California, San Diego - School of Medicine, further specializing in Neurology Residency Program at the University of Michigan Medical School and Internal Medicine Residency Program at the University of Rochester School of Medicine and Dentistry.

Additionally, Mike completed his undergraduate studies with an A.B. from the University of California, Berkeley, showcasing a strong academic foundation.

Throughout his career, Mike Poole has held several key positions in prestigious organizations, including being the Head of Research and Development at a Biotechnology company, serving as a Senior Advisor for COVID-19 Therapeutics Accelerator at the Bill & Melinda Gates Foundation, and acting as a Venture Partner at Biomatics Capital, Inc.

His previous roles also include Director of the Office of the President for Global Health at the Bill and Melinda Gates Foundation, Head of the Neuroscience Innovative Medicines Unit at AstraZeneca, Chief Medical Officer at Link Medicine, and various leadership positions at Pfizer and Hypnion in the field of Neuroscience.

Mike's extensive experience in research, development, and leadership roles within the healthcare and biotechnology sectors highlights his expertise and contributions to the advancement of medical science and global health initiatives.